{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:10:26Z","timestamp":1778127026384,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2006,3,29]],"date-time":"2006-03-29T00:00:00Z","timestamp":1143590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1038\/sj.ijo.0803272","type":"journal-article","created":{"date-parts":[[2006,3,29]],"date-time":"2006-03-29T12:23:31Z","timestamp":1143635011000},"page":"S13-S18","source":"Crossref","is-referenced-by-count":452,"title":["The pharmacology of cannabinoid receptors and their ligands: an overview"],"prefix":"10.1038","volume":"30","author":[{"given":"R G","family":"Pertwee","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2006,3,29]]},"reference":[{"key":"BF0803272_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002; 54: 161\u2013202.","journal-title":"Pharmacol Rev"},{"key":"BF0803272_CR2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TT . Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561\u2013564.","journal-title":"Nature"},{"key":"BF0803272_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M . Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61\u201365.","journal-title":"Nature"},{"key":"BF0803272_CR4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3565(24)35181-X","volume":"291","author":"J Mu","year":"1999","unstructured":"Mu J, Zhuang S-Y, Kirby MT, Hampson RE, Deadwyler SA . Cannabinoid receptors differentially modulate potassium A and D currents in hippocampal neurons in culture. J Pharmacol Exp Ther 1999; 291: 893\u2013902.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF0803272_CR5","first-page":"1","volume-title":"Cannabinoids. Handbook of Experimental Pharmacology","author":"RG Pertwee","year":"2005","unstructured":"Pertwee RG . Pharmacological actions of cannabinoids. In: Pertwee RG (ed) Cannabinoids. Handbook of Experimental Pharmacology. Springer-Verlag: Heidelberg, 2005, pp 1\u201351."},{"key":"BF0803272_CR6","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.neuropharm.2005.01.010","volume":"48","author":"RG Pertwee","year":"2005","unstructured":"Pertwee RG, Thomas A, Stevenson LA, Maor Y, Mechoulam R . Evidence that (\u2013)-7-hydroxy-4\u2032-dimethylheptyl-cannabidiol activates a non-CB1, non-CB2, non-TRPV1 target in the mouse vas deferens. Neuropharmacology 2005; 48: 1139\u20131146.","journal-title":"Neuropharmacology"},{"key":"BF0803272_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0163-7258(02)00257-7","volume":"95","author":"EM Berry","year":"2002","unstructured":"Berry EM, Mechoulam R . Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacol Ther 2002; 95: 185\u2013190.","journal-title":"Pharmacol Ther"},{"key":"BF0803272_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","volume":"63","author":"RG Pertwee","year":"2001","unstructured":"Pertwee RG . Cannabinoid receptors and pain. Prog Neurobiol 2001; 63: 569\u2013611.","journal-title":"Prog Neurobiol"},{"key":"BF0803272_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/1570159043476927","volume":"2","author":"RG Pertwee","year":"2004","unstructured":"Pertwee RG . Novel pharmacological targets for cannabinoids. Curr Neuropharmacol 2004; 2: 9\u201329.","journal-title":"Curr Neuropharmacol"},{"key":"BF0803272_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/sj.bjp.0705666","volume":"141","author":"L De Petrocellis","year":"2004","unstructured":"De Petrocellis L, Cascio MG, Di Marzo V . The endocannabinoid system: a general view and latest additions. Br J Pharmacol 2004; 141: 765\u2013774.","journal-title":"Br J Pharmacol"},{"key":"BF0803272_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1054\/plef.2001.0341","volume":"66","author":"RG Pertwee","year":"2002","unstructured":"Pertwee RG, Ross RA . Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 2002; 66: 101\u2013121.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"BF0803272_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0163-7258(02)00255-3","volume":"95","author":"RG Pertwee","year":"2002","unstructured":"Pertwee RG . Cannabinoids and multiple sclerosis. Pharmacol Ther 2002; 95: 165\u2013174.","journal-title":"Pharmacol Ther"},{"key":"BF0803272_CR13","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1124\/jpet.301.3.1020","volume":"301","author":"AC Porter","year":"2002","unstructured":"Porter AC, Sauer J-M, Knierman MD, Becker GW, Berna MJ, Bao J et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 2002; 301: 1020\u20131024.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF0803272_CR14","first-page":"129","volume":"74","author":"RG Pertwee","year":"1997","unstructured":"Pertwee RG . Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 1997; 74: 129\u2013180.","journal-title":"Pharmacol Ther"},{"key":"BF0803272_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1615\/CritRevNeurobiol.v15.i2.10","volume":"15","author":"LJ Sim-Selley","year":"2003","unstructured":"Sim-Selley LJ . Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Crit Rev Neurobiol 2003; 15: 91\u2013119.","journal-title":"Crit Rev Neurobiol"},{"key":"BF0803272_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0091-3057(96)00379-6","volume":"58","author":"P Massi","year":"1997","unstructured":"Massi P, Patrini G, Rubino T, Fuzio D, Parolaro D . Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study. Pharmacol Biochem Behav 1997; 58: 73\u201378.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF0803272_CR17","doi-asserted-by":"publisher","first-page":"20397","DOI":"10.1074\/jbc.274.29.20397","volume":"274","author":"M Bouaboula","year":"1999","unstructured":"Bouaboula M, Dussossoy D, Casellas P . Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528: implications for receptor biological responses. J Biol Chem 1999; 274: 20397\u201320405.","journal-title":"J Biol Chem"},{"key":"BF0803272_CR18","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.lfs.2004.10.025","volume":"76","author":"RG Pertwee","year":"2005","unstructured":"Pertwee RG . Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci 2005; 76: 1307\u20131324.","journal-title":"Life Sci"},{"key":"BF0803272_CR19","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1124\/mol.54.6.1064","volume":"54","author":"X Pan","year":"1998","unstructured":"Pan X, Ikeda SR, Lewis DL . SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity. Mol Pharmacol 1998; 54: 1064\u20131072.","journal-title":"Mol Pharmacol"},{"key":"BF0803272_CR20","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/sj.bjp.0705577","volume":"140","author":"JR Savinainen","year":"2003","unstructured":"Savinainen JR, Saario SM, Niemi R, J\u00e4rvinen T, Laitinen JT . An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors. Br J Pharmacol 2003; 140: 1451\u20131459.","journal-title":"Br J Pharmacol"},{"key":"BF0803272_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1124\/mol.60.1.155","volume":"60","author":"CS Breivogel","year":"2001","unstructured":"Breivogel CS, Griffin G, Di Marzo V, Martin BR . Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 2001; 60: 155\u2013163.","journal-title":"Mol Pharmacol"},{"key":"BF0803272_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrc1188","volume":"3","author":"M Guzm\u00e1n","year":"2003","unstructured":"Guzm\u00e1n M . Cannabinoids: potential anticancer agents. Nat Rev Cancer 2003; 3: 745\u2013755.","journal-title":"Nat Rev Cancer"},{"key":"BF0803272_CR23","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1136\/bjo.2003.032250","volume":"88","author":"I Tomida","year":"2004","unstructured":"Tomida I, Pertwee RG, Azuara-Blanco A . Cannabinoids and glaucoma. Br J Ophthalmol 2004; 88: 708\u2013713.","journal-title":"Br J Ophthalmol"},{"key":"BF0803272_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0009-3084(02)00155-X","volume":"121","author":"TP Malan","year":"2002","unstructured":"Malan TP, Ibrahim MM, Vanderah TW, Makriyannis A, Porreca F . Inhibition of pain responses by activation of CB2 cannabinoid receptors. Chem Phys Lipids 2002; 121: 191\u2013200.","journal-title":"Chem Phys Lipids"},{"key":"BF0803272_CR25","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","volume":"365","author":"LF Van Gaal","year":"2005","unstructured":"Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, R\u00f6ssner S . Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005; 365: 1389\u20131397.","journal-title":"Lancet"},{"key":"BF0803272_CR26","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa044537","volume":"353","author":"J-P Despr\u00e9s","year":"2005","unstructured":"Despr\u00e9s J-P, Golay A, Sj\u00f6str\u00f6m L . Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2005; 353: 2121\u20132134.","journal-title":"N Engl J Med"},{"key":"BF0803272_CR27","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/sj.bjp.0705711","volume":"141","author":"TJ Price","year":"2004","unstructured":"Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM . Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br J Pharmacol 2004; 141: 1118\u20131130.","journal-title":"Br J Pharmacol"},{"key":"BF0803272_CR28","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/sj.bjp.0705902","volume":"142","author":"CL Baker","year":"2004","unstructured":"Baker CL, McDougall JJ . The cannabinomimetic arachidonyl-2-chloroethylamide (ACEA) acts on capsaicin-sensitive TRPV1 receptors but not cannabinoid receptors in rat joints. Br J Pharmacol 2004; 142: 1361\u20131367.","journal-title":"Br J Pharmacol"},{"key":"BF0803272_CR29","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1124\/mol.105.016162","volume":"68","author":"MR Price","year":"2005","unstructured":"Price MR, Baillie GL, Thomas A, Stevenson LA, Easson M, Goodwin R et al. Allosteric modulation of the cannabinoid CB1 receptor. Mol Pharmacol 2005; 68: 1484\u20131495.","journal-title":"Mol Pharmacol"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/0803272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0803272","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0803272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T05:10:34Z","timestamp":1736313034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/0803272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,29]]},"references-count":29,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["BF0803272"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijo.0803272","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,29]]}}}